Olivier Gouédard
Chief Operating Officer at Cytovia Therapeutics, Inc.
Olivier Gouédard active positions
| Companies | Position | Start | End |
|---|---|---|---|
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Chief Operating Officer | 21/06/2021 | - |
Career history of Olivier Gouédard
Training of Olivier Gouédard
| New York University | Masters Business Admin |
| Université Paris-Saclay | Undergraduate Degree |
| University of Rennes | Doctorate Degree |
Statistics
International
| United States | 3 |
| France | 3 |
Operational
| Chief Operating Officer | 1 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Olivier Gouédard
- Experience
